Lippincott Pharmacology Practice Exam

Amphetamines are indicated for use in the management of obesity, particularly in cases where lifestyle changes such as diet and exercise have not been effective. They act as central nervous system stimulants, increasing energy expenditure and reducing appetite, which can contribute to weight loss. Their efficacy in promoting weight loss makes them a potential option in a medically supervised weight management program.

In contrast, amphetamines are generally contraindicated in conditions like cardiovascular disease and hypertension due to their stimulant effects, which can exacerbate these conditions by increasing blood pressure and heart rate. Similarly, in hyperthyroidism, amphetamines can intensify the symptoms or risks associated with an overactive thyroid. These potential health risks underscore why the other options do not align with the therapeutic use of amphetamines.